A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease
Clinical trial NCT05104463 · COMPLETED
Trial details
- NCT number
- NCT05104463
- Sponsor
- CuraSen Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-12-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.